Comprehensive Screening of Drug Encapsulation and Co-Encapsulation into Niosomes Produced Using a Microfluidic Device


Authors: S. Joshi, R. White, R. Sahu, V.A. Dennis and S.R. Singh

Journal: Processes

DOI: 10.3390/pr8050535

Publication - Abstract

May 02, 2020

Small Molecule Drugs Other Formulations

Abstract

Microfluidics is a very facile and fast method of particulate production. Besides, it enables the manufacturing of size tuned particulate systems. Niosomes due to structural similarities have importance as alternative drug delivery systems to liposomes. Niosomes can be encapsulated or co-encapsulated with hydrophilic and lipophilic drugs. The research presented here includes the optimization of method parameters for niosome production as well as evaluation of the efficiency of microfluidics to encapsulate and co-encapsulate the drugs. For this purpose, metformin (MET) and garcinol (GC) were the model drugs. Two different non-ionic surfactants (NIS), namely Tween-20 and Span-60 with significant difference in hydrophilic-lipophilic balance (HLB) value, were chosen to analyze their efficiency to form niosomes and encapsulate one or more drugs.

limit search to this category
Advanced Search

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Sep 06, 2019
Small

Phospholipid‐Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver

W. Zhang, R. Böttger, Z. Qin, J.A. Kulkarni, J. Vogler, P.R. Cullis, and S-D. Li

Small Molecule Drugs
It is reported that cholesterol (Chol) and TWEEN 80 at a molar ratio of 5:1 can form small unilamellar vesicles (SUVs) using a staggered herringbone micromixer. These phospholipid‐free SUVs (PFSUVs) can be actively loaded with a model drug for targeting hepatocytes via the endoge...
Read More


Publication - Abstract

Apr 09, 2015
Journal of Liposome Research

Production of Limit Size Nanoliposomal Systems with Potential Utility as Ultra-Small Drug Delivery Agents

I.V. Zhigaltsev, Y.K. Tam, A.K. Leung and P.R. Cullis

mRNA Other Formulations Liposomes

Previous studies from this group have shown that limit size lipid-based systems—defined as the smallest achievable aggregates compatible with the packing properties of their molecular constituents—can be efficiently produced using a&nbs...

Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Cytiva, formerly Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
Sign Up